Acquisition of an xCELLigence RTCA-MP Equipment Package

Contracting Office Address:Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions, 9609 Medical Center Drive, Room 1E144, Bethesda, MD 20892, UNITED STATESDescription:The National Cancer Institute (NCI), Center of Cancer Research (CCR), Laboratory of Tumor Immunology and Biology (LTIB), plans to procure, on a sole source basis, an xCELLigence RTCA-MP Equipment Package by Acea Biosciences, 6779 Mesa Ridge Road #100; San Diego, CA 92121.The response close date of this notice for this requirement is in accordance with FAR 5.203(a)(1). This acquisition will be processed under FAR Part 12 - Acquisition for Commercial Items and in accordance with simplified acquisition procedures as stated in FAR Part 13.106-1(b)(2) and is exempt from the requirements of FAR Part 6. The North American Industry Classification System (NAICS) code is 334516 and the business size standard is 1,000 employees.Only one (1) award will be made as a

result of this solicitation. This will be awarded as a firm fixed price type contract.The period of performance: delivery will be within 90 days from date of award.It has been determined there are no opportunities to acquire green products or services for this procurement.The Laboratory of Tumor Immunology and Biology (LTIB) requires an xCelligence RTCA-MP package to develop novel immunotherapeutic treatments for human carcinoma, and to measure cytoxicity of tumor cells in real time over 96 hours in a non-radioactive manner. One aspect of the LTIB's studies is identifying and quantifying the impact of its various treatments on the lysis of various tumor cell lines. It currently performs these assays utilizing a radioactive technology, which is limited to 5h cytotoxicity measurements. The need that this equipment satisfies is to achieve an essential aspect of its research program, which aims to provide the pre-clinical rationale for all of the clinical trials performed by the LTIB within the National Cancer Institute.The Contractor shall provide the following:TECHNICAL REQUIREMENTS: Specifications/characteristics that are required include:One (1) - RTCA MP Station with the following specifications:• Electrical interface: handles six (6) 96-well electronic microtiter plates• Plate interface time: less than five (5) seconds for each plate• Measurement rate: <10 seconds per measurement for one (1) electronic microtiter plate or muirca@mail.nih.gov. A determination by the Government not to compete this proposed requirement based upon responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. No collect calls will be accepted. In order to receive an award, Contractors must be registered and have valid, current Entity Record, including current Representations and Certifications, in the System for Award Management (SAM) through SAM.gov. Reference: N02RC72559-76 on all correspondence.Contact Information: Catherine Muir, Contracting Officer, Phone (240) 276-5434, Fax (240) 276-5401 , Email muirca@mail.nih.gov Office Address :9609 Medical Center Drive, Room 1E128 Rockville MD 20852 Location: National Cancer Institute, Office of Acquisitions Set Aside: N/A